Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sigyn Therapeutics Inc
(OP:
SIGY
)
5.750
UNCHANGED
Last Price
Updated: 11:55 AM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sigyn Therapeutics Inc
< Previous
1
2
3
Next >
OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand Viewing
August 02, 2024
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Announces Q1 2024 Financial Results
May 15, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
May 15, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
May 15, 2024
SAN DIEGO, CA - (NewMediaWire) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for...
Via
TheNewswire.com
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces Publication of Article on Emerging Candidate – Sigyn Therapy(TM)
May 07, 2024
Via
Investor Brand Network
Topics
Death
Exposures
COVID-19
Death
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
May 07, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
April 12, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics Inc. (SIGY) CEO Discusses Company’s Blood Purification Therapies to Address Cancer and Other Life-Threatening Conditions at the Emerging Growth Conference
April 01, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Making Drugs Perform Better
March 27, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Developing Innovative Technologies to Address Critical Healthcare Challenges
March 20, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Filling Gap in Therapeutic Antibody Treatment Space
March 15, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces CEO Presentation at Upcoming Emerging Growth Conference
March 05, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
March 05, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn Therapeutics Inc. (SIGY) Therapeutic Candidates to Overcome Limitations in Healthcare
March 05, 2024
Via
Investor Brand Network
Sigyn Therapeutics Inc. (SIGYD) Completes Reverse Stock Split, Releases Year-End Financial Report for 2023
February 27, 2024
Via
Investor Brand Network
Sigyn Therapeutics Announces Filing of 2023 Annual Report on SEC Form 10-K
February 21, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY, SIGYD) Announces Implementation of a 1-for-40 Reverse Split
February 02, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics Completes Reverse Stock Split
February 01, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
InvestorNewsBreaks – Sigyn Therapeutics Inc. (SIGY) to Implement 1-for-40 Reverse Split
January 30, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics Announces Reverse Stock Split
January 30, 2024
SAN DIEGO, CA - (NewMediaWire) - January 30, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced that a 1-for-40...
Via
NewMediaWire
Sigyn Therapeutics Announces Reverse Stock Split
January 30, 2024
SAN DIEGO, CA - (NewMediaWire) - January 30, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced that a 1-for-40...
Via
TheNewswire.com
BioMedNewsBreaks — Why Sigyn Therapeutics Inc. (SIGY) Is ‘One to Watch’
January 24, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics Inc. (SIGY) Is ‘One to Watch’
January 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) CEO Releases Shareholder Letter Outlining Opportunities, Challenges, Processes
January 04, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Product Safety
Sigyn Therapeutics Releases Letter to Shareholders
January 04, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer
December 12, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Sigyn Therapeutics Reports Third Quarter 2023 Financial Results
November 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn Therapeutics Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity
October 04, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
Economy
Intellectual Property
Exposures
Death
Intellectual Property
Supply Chain
Sigyn Therapeutics to Present at Today's Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conference
September 06, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn Therapeutics Reports Second Quarter 2023 Financial Results
August 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.